FIELD: biotechnology.
SUBSTANCE: method of production of bacteriophage comprises: inoculation with the bacterial culture of the host strain in the titre of 108-109 CFU/ml in the vessel for culturing on the slant having a layer thickness from 10 mm to 25 mm, culturing for 3-3.5 hours at optimum temperature for growth of the host strain culture, then on the resulting lawn of culture of the host strain the stock bacteriophage is inoculated in the titre 105-106 CFU/ml and cultured for 13-15 hours at the optimum temperature and the thickness of the air layer over the surface of the solid medium of 25 mm to 40 mm. the phage lysate is prepared and sucked into a sterile container, chloroform is added, incubated for 30-45 minutes with continuous shuttling. The supernatant is centrifuged and sterilised by filtration through the filter with a pore diameter of 0.2-0.22 microns.
EFFECT: solution provides the universal possibility of production of phage lysate with use of different bacteriophages, stability of bacteriophage titre in phage lysate and the possibility of its use in the food industry.
3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING BACTERIOPHAGE | 2015 |
|
RU2603730C1 |
BACTERIOPHAGES PRODUCTION METHOD | 2015 |
|
RU2613423C1 |
ANTIBACTERIAL COMPOSITION FOR THE EXTENSION OF THE EXPIRY DATE OF FROZEN FISH AND THE RISK REDUCTION OF FOOD-INFECTION-BASED INFECTIONS, BACTERIOPHAGIC STAMPS USED FOR ITS OBTAINING | 2016 |
|
RU2644667C1 |
ANTIBACTERIAL COMPOSITION BASED ON STRAINS OF BACTERIOPHAGES FOR PREVENTING OR TREATING SALMONELLOSIS AND / OR ESCHERICHIOSIS OF FARM ANIMALS OR BIRDS OR HUMANS | 2019 |
|
RU2705302C1 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
ANTIBACTERIAL COMPOSITION IN FORM OF SUPPOSITORY AND METHOD OF ITS PREPARATION | 2016 |
|
RU2622762C1 |
ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730613C1 |
BACTERIOPHAGE-CONTAINING ROOM DEODORANT | 2014 |
|
RU2574023C2 |
ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730614C1 |
ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST GRAM-NEGATIVE BACTERIA: PSEUDOMONAS AERUGINOSA, ACINETOBACTER BAUMANNII, KLEBSIELLA PNEUMONIAE AND SALMONELLA TYPHI (EMBODIMENTS) | 2019 |
|
RU2730615C1 |
Authors
Dates
2014-08-10—Published
2013-06-07—Filed